NanoViricides, Inc. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was USD 8.59 million compared to USD 8.11 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 0.7 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | -0.57% |
|
+1.74% | +71.57% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.57% | 20.67M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- NNVC Stock
- News NanoViricides, Inc.
- NanoViricides, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023